The use of products derived from neonatal prepuces has been a focus in several "intactivism" forums. This would appear to be unique opportunity to bring your concerns directly to the attention of regulators. The outcomes of this meeting will have ramifications both in the United States and internationally. They are accepting both written and oral submissions, so it would appear that members around the world can lodge a submission.
From the "Resources for You" section:
'SUMMARY: The Food and Drug Administration (FDA) is announcing a public
meeting entitled ``International Cooperation on Cosmetics Regulations
(ICCR)--Preparation for ICCR-5 Meeting in Paris, France'' to provide
information and receive comments on the International Cooperation on
Cosmetics Regulations (ICCR) as well as the upcoming meetings in Paris,
France. The topics to be discussed are the topics for discussion at the
forthcoming ICCR Steering Committee meeting. The purpose of the meeting
is to solicit public input prior to the next steering committee and
expert working group meetings in Paris, France scheduled on June 28
through July 1, 2011.
DATES: Date and Time: The public meeting will be held on April 26,
2011, from 2 p.m. to 4 p.m.
Location: The public meeting will be held at the Washington Theater
room at the Hilton Washington DC/Rockville Hotel & Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: All participants must register with Kimberly
Franklin, Office of the Commissioner, Food and Drug Administration,
10903 New Hampshire Ave., Silver Spring, MD 20993-0002, e-mail:
Kimberly.Franklin@fda.hhs.gov, or Fax: 301-595-7937.
Registration and Requests for Oral Presentations: Send registration
information (including name, title, firm name, address, telephone, and
fax number), written material, and requests to make oral presentations,
to the contact person by April 22, 2011.
If you need special accommodations due to a disability, please
contact Kimberly Franklin (see Contact Person) at least 7 days in
Interested persons may present data, information, or views orally
or in writing, on issues pending at the public meeting. Time allotted
for oral presentations may be limited to 10 minutes. Those desiring to
make oral presentations should notify the contact person by April 22,
2011, and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses,
telephone number, fax, and e-mail of proposed participants, and an
indication of the approximate time requested to make their